about
Downregulation of E-cadherin and Desmoglein 1 by autocrine hepatocyte growth factor during melanoma developmentThe G-protein coupled receptor associated sorting protein GASP-1 regulates the signalling and trafficking of the viral chemokine receptor US28.High-contrast coherent terahertz imaging of porcine tissue via swept-frequency feedback interferometry.A stress-induced early innate response causes multidrug tolerance in melanoma.A systematic review of non-surgical treatments for lentigo maligna.Gα13 mediates human cytomegalovirus-encoded chemokine receptor US28-induced cell death in melanoma.Notch4 Signaling Induces a Mesenchymal-Epithelial-like Transition in Melanoma Cells to Suppress Malignant Behaviors.In search of a novel target - phosphatidylserine exposed by non-apoptotic tumor cells and metastases of malignancies with poor treatment efficacyTranscriptional activation of ZEB1 by Slug leads to cooperative regulation of the epithelial-mesenchymal transition-like phenotype in melanoma.The cadherin switch in melanoma instigated by HGF is mediated through epithelial-mesenchymal transition regulators.Human lactoferricin derived di-peptides deploying loop structures induce apoptosis specifically in cancer cells through targeting membranous phosphatidylserine.Toxicity of oxidized phosphatidylcholines in cultured human melanoma cells.miR-206 controls LXRα expression and promotes LXR-mediated cholesterol efflux in macrophagesKilling of melanoma cells and their metastases by human lactoferricin derivatives requires interaction with the cancer marker phosphatidylserineNR4A1-mediated apoptosis suppresses lymphomagenesis and is associated with a favorable cancer-specific survival in patients with aggressive B-cell lymphomas.TGF-β1 and TNF-α differentially regulate Twist1 mediated resistance towards BRAF/MEK inhibition in melanoma.Two Case Reports of Rare BRAF Mutations in Exon 11 and Exon 15 with Discussion of Potential Treatment Options.Diphenylcyclopropenone for the treatment of cutaneous in-transit melanoma metastases - results of a prospective, non-randomized, single-centre study.HGF-promoted motility in primary human melanocytes depends on CD44v6 regulated via NF-kappa B, Egr-1, and C/EBP-beta.A petrol ether extract of the roots of Onosma paniculatum induces cell death in a caspase dependent manner.Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients.Profiles of chemokine receptors in melanocytic lesions: de novo expression of CXCR6 in melanoma.The BRAF and NRAS mutation prevalence in dermoscopic subtypes of acquired naevi reveals constitutive MAPK pathway activation.Heritability of naevus patterns in an adult twin cohort from the Brisbane Twin Registry: a cross-sectional study.Application of alpha-aminoisobutyric acid, L-methionine, thymidine and 2-fluoro-2-deoxy-D-glucose to monitor effects of chemotherapy in a human colon carcinoma cell line.Combination treatment based on metabolic effects of dinaline.Tumor-associated B-cells induce tumor heterogeneity and therapy resistance.Naphthoquinones from Onosma paniculata induce cell-cycle arrest and apoptosis in melanoma Cells.Protocol for the TIDAL Melanoma Study: topical imiquimod or diphenylcyclopropenone for the management of cutaneous in-transit melanoma metastases-a phase II, single centre, randomised, pilot study.Classifying dermoscopic patterns of naevi in a case-control study of melanoma.Pregnancy as a driver for melanoma.Stroma formation and angiogenesis by overexpression of growth factors, cytokines, and proteolytic enzymes in human skin grafted to SCID mice.Overcoming resistance to targeted therapy with immunotherapy and combination therapy for metastatic melanoma.BRAFV600E mutation status of involuting and stable nevi in dabrafenib therapy with or without trametinib.Lack of oncogenic mutations in the c-Met catalytic tyrosine kinase domain in acral lentiginous melanoma.Carbamazepine as the only effective treatment in a 52-year-old man with trigeminal trophic syndrome.Chemokine receptors in gastric MALT lymphoma: loss of CXCR4 and upregulation of CXCR7 is associated with progression to diffuse large B-cell lymphoma.Co-culture of human fibroblasts and Borrelia burgdorferi enhances collagen and growth factor mRNA.The evolving universe of BRAF mutations in melanoma.A distinct expression profile separates Turkish and Australian melanocytic naevi.
P50
Q28214978-DB590696-B794-47AF-B433-D239FF551995Q34282400-C0290B73-401C-4756-8B3E-AE7CD7414823Q35451202-6EFDFCB3-BCF9-4DA4-89D9-7F47EBEDF7E8Q35639898-F9608175-893E-40B9-9A8F-A00D06677589Q35753267-AEA3DB90-4011-41EE-99C0-63ABCA69F6B5Q35832550-57D599AA-FCFB-4B3B-A1B6-21AE8874DE22Q37515480-F44976AC-A28C-4243-B524-57D05443C103Q38491362-507D8AA2-A71A-4C47-9E0D-B8692DF6C288Q38587374-EAB90558-C915-4CCA-A5E6-3CB892BCB9A3Q38668193-E78BF0AC-06A4-4956-AE47-5DDA135D2747Q38846599-8C9197D6-35F6-47AB-9E50-F05F3EB859ECQ38869052-66D32A29-8E69-4637-9BC3-16F2F60674F4Q38916069-57FBBCDC-E00A-4169-A0E3-DE81AF550714Q38994009-50D2BDE0-016E-4CC3-9911-DF0E0567B31BQ39022425-EB520322-3E04-4D0A-B94E-3D6A1BC4D7DCQ39126744-FDF80B0D-A50E-4E7F-8131-8F95FD80B892Q39240981-4D481CCC-37E8-481D-BFE4-7A344AC65F0BQ39381921-DD02E355-8149-433F-90F7-43AD711D9114Q39720254-1DE238B7-C3FB-4B37-908E-44E3CA956137Q39728166-E737ED94-581E-47BA-8C16-A6356BDA8A97Q39907017-385972E0-69CF-4505-9D09-FA6B3760E17CQ40170184-46AC6CCC-8C8D-459E-AEAE-C2B60D5DB2D4Q40486979-7F0E6DFB-BCC6-4E0E-80DD-259C6483D4BEQ40913284-AB463BC3-2A36-4090-9B23-3471D346B4F9Q41254329-B1D04F45-AE0E-4E6B-B044-63095119B44CQ41394133-0D59F905-1B44-4966-874D-39DF94857EE5Q41701119-DEEE9B15-D16D-4223-B7B9-C2DAA0C4AFF6Q42178191-05FFDE27-340A-4AC6-8EA8-C071197DC4B2Q42376753-1127637D-1D5D-47B0-B370-E32305A57E9CQ42685168-5940AA18-3257-486A-8BD4-2FA6B538F241Q43461357-1982295C-FFDD-467A-8DA8-ADAF8D968B5AQ44369519-AEE144D3-D408-4A72-BAA1-52FE2D64CDD9Q45121629-AC9687CB-C4A4-4BBC-A7BB-52DA2488FDCCQ45775059-2A32E0E4-6B84-4DCA-A948-C89268BF01A4Q46173676-AEBAB691-F016-48AE-8F3E-451912A14697Q46670468-F1F91ED5-C22A-4F81-87EF-FFEC7CEC3B08Q46818183-96EC769A-ED75-4A09-A5B2-D19E15EC9081Q47321312-77137362-B688-4508-BE8C-5DDA23F5E4AAQ47624970-D99F4F1B-CD68-451F-AAC3-276114C04D0FQ47823936-8C60699D-07CD-464F-8E47-96BBD428575D
P50
description
researcher ORCID ID = 0000-0003-3195-2517
@en
wetenschapper
@nl
name
Helmut Schaider
@ast
Helmut Schaider
@en
Helmut Schaider
@es
Helmut Schaider
@nl
type
label
Helmut Schaider
@ast
Helmut Schaider
@en
Helmut Schaider
@es
Helmut Schaider
@nl
prefLabel
Helmut Schaider
@ast
Helmut Schaider
@en
Helmut Schaider
@es
Helmut Schaider
@nl
P106
P21
P31
P496
0000-0003-3195-2517